Hetero-tricyclic compounds as inhibitors of KRAS
US12030883B2 · kind B2 · utility
0Cited by
25References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2022 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | Sep 20, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.